Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Synthesis Global Health Journal Indonesian Journal of Biomedicine and Clinical Sciences Indonesian Journal of Pharmacology and Therapy
Kurniaty, Linggom
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Perception and use of herbal medicine by Indonesian Medical Doctors Simatupang, Abraham; Widyawati, Tri; Susilaningsih, Neni; Tobing, Romauli; Kurniaty, Linggom; Silaban, Hertina; Djojosaputro, Mulyadi; Mahabuana, Bintang
Indonesian Journal of Biomedicine and Clinical Sciences Vol 57 No 1 (2025)
Publisher : Published by Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/inajbcs.v57i1.15768

Abstract

Indonesia has a long experience in traditional medicine such as jamu. The government has been encouraging all sectors, especially pharmaceutical industries together with research institutions and academia to increase herbal medicine research so that herbal medicine is increasingly used in health services, including by medical doctors. Various efforts have been made but empirically it seems that this goal has not been achieved. For this reason, it is necessary to conduct a survey to determine the understanding and use of herbal medicine among doctors. I was a cross-sectional study using an electronic questionnaire distributed to doctors who are members of the Indonesian Medical Association (IMA) per province. Three-hundred sixty-two respondents from 29 out of 38 (76%) provinces of Indonesia responded, and 263 out 362 respondents (72%) are general practitioners. In prescribing herbal medicines only 18.5% prescribed, 35% did not and 46.6% sometimes prescribed, respectively. Of the eleven phytopharmaceuticals/standardised herbal medicines only one medicine No. 5 was widely recognized by respondents (46.6%). This study showed that doctors' understanding of herbal medicine still needs to be improved through various means including webinars/seminars, journals that show good clinical trials so that they are more confident when prescribing herbal medicine to their patients. There is a need for more comprehensive information regarding the indications, efficacy and side effects of herbal medicine, through books or formularies that can be accessed by doctors. In addition, respondents agreed that herbal medicine should be taught in medical schools both in the pre-clinical and clinical phases.
Knowledge of hypertension and its therapy in lay people Simatupang, Abraham; Sitompul, Fransiska; Kurniaty, Linggom; Djojosaputro, Mulyadi; Lumbantobing, Romauli; Silaban, Hertina
Indonesian Journal of Pharmacology and Therapy Vol 3 No 3 (2022)
Publisher : Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada and Indonesian Pharmacologist Association or Ikatan Farmakologi Indonesia (IKAFARI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ijpther.4468

Abstract

Hypertension is one of the non-communicable diseases that is becoming a global health problem. Hypertension can be identified by systolic blood pressure of 140 mmHg and diastolic 90 mmHg . Uncontrolled hypertension can lead to complications such as stroke, ischemic heart disease, heart attack, heart failure, kidney failure, blindness, etc. According to Basic Health Research 2018 ( Ris et Kesehatan Dasar 2018/Ris kesdas 2018) the prevalence of hypertension for >18 years old wa s 8.4%, and through measurements taken in health care facilities by 34.1%. Prevalence in the city was 34.4%, in the village was 33.7%, while according to gender 31.3% f or male and 36.9% for female. The study aimed to find out the knowledge and awareness of laypeople on hypertension and its therapy. This was a cross-sectional online study with 11 questions. Respondents were recruited from social media groups. The results showed 5 00 respondents (62.8 % female and 37.2 % male) involved in this study . The most common age range was 21-40 years (36.2 %), followed by 41-55 years (38.2%) , and the least was 56-65 years old (18.4%). Seventy-two percent of respondents did not have hypertension, and 9% said they did not know. Fifty-three percent of respondents knew about the value of high blood pressure, and 89% of the respondents said hypertension should be treated regularly. The most hypertension complications answered by respondents were stroke (40%), heart attack (26%) , and heart failure (16%). Amlodipine was the most mentioned by the respondents, and the second was ACE-inhibitor. However, omeprazole and omega-3 were also mentioned as anti-hypertension. Genetic s and a high salt diet were risk factors that many respondents chose. In conclusi on, the r espondents have a good understanding of hypertension. Information related to behaviour is needed to discontinue the increasing prevalence.
COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF OLD AND NEW TB DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS Lumbantobing, Romauli; Kurniaty, Linggom; Salutondok, Welly; Simanjuntak, Tiroy Sari B.
SYNTHESIS Global Health Journal Volume 3, Issue 2, 2025
Publisher : SYNTIFIC

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61543/syn.v3i2.148

Abstract

Background. The availability of effective drug regimens of Pulmonary tuberculosis (TB) poses a global health challenge. Traditional first-line therapies-isoniazid, rifampicin, pyrazinamide, and ethambutol-remain the cornerstone of TB management due to their accessibility and documented cure rates exceeding 85%. Nevertheless, limitations such as variable drug metabolism, patient non-adherence, and the emergence of multidrug-resistant strains have prompted evaluation of newer treatment combinations to optimize efficacy, safety, and duration. The purpose was to compare the effectiveness of older first-line tuberculosis (TB) drug regimens with newer therapeutic regimens in the treatment of pulmonary tuberculosis. Research Method. This narrative review synthesizes findings from five peer-reviewed studies comparing the effectiveness and safety profiles of conventional and novel TB drug regimens. The review focused on regimen composition, treatment duration, bacteriological clearance, hepatotoxicity, and patient adherence outcomes. Findings. The inclusion of pyrazinamide in six-month regimens significantly accelerated bacterial clearance without increasing hepatic toxicity compared to traditional nine-month isoniazid–rifampicin regimens. Additionally, shorter rifampin-based regimens for latent TB demonstrated higher treatment completion rates and fewer adverse effects than isoniazid monotherapy. Emerging regimens, such as fluoroquinolone-based HRM therapies and the novel BPaL combination (bedaquiline, pretomanid, and linezolid), yielded comparable or improved outcomes, with BPaL achieving success rates up to 93% in drug-resistant TB cases. Conclusion. Current evidence supports the strategic adaptation of TB therapy to balance efficacy, tolerability, and treatment duration. Incorporating newer drug combinations, particularly for drug-resistant TB, enhances adherence and clinical outcomes, underscoring the need for individualized treatment protocols aligned with evolving resistance patterns and patient profiles.
Co-Authors Abraham Simatupang Lumbantobing, Romauli Mahabuana, Bintang Mulyadi Djojosaputro, Mulyadi Neni Susilaningsih Salutondok, Welly Silaban, Hertina Simanjuntak, Tiroy Sari B. Sitompul, Fransiska Tobing, Romauli Tri Widyawati, Tri